NTI Upstream 2017 Webinar Series

This year we're offering a "best of" series, consisting of our most popular webinars from over the last several years and those most frequently requested to be repeated. Join us for these engaging and informative webinars presented by Dr. Ira J. Chasnoff.

 

2017 Webinar 1:

Adolescents with FASD

March 8, 11:00-12:15 p.m. Pacific Time, 1:00 - 2:15 p.m. Central Time, 2:00-3:15 p.m. Eastern time

In this unique webinar, we will explore the manifestation of prenatal alcohol exposure in the adolescent.  The neurocognitive, adaptive and regulatory functioning deficits common in individuals with FASD translate into daily challenges for the adolescent, ranging across behavioral, developmental and academic domains.  Effective strategies for helping the young person at home and at school will be discussed.


2017 Webinar 2:

The Biological Basis of Attachment Difficulties in

Infants with prenatal substance exposure

April 25, 11:00-12:15 p.m. Pacific Time, 1:00 - 2:15 p.m. Central Time, 2:00-3:15 p.m. Eastern time

Attachment is the interconnectedness between human beings.  Attachment requires reading each other’s cues and responding appropriately to each other’s cues.  The important thing to realize is that attachment is a two-way street, and not only must the mother be able to read the infant’s cues, but the infant must be able to read the mother’s cues.  Unfortunately, the neurobehavioral impact of prenatal substance exposure on the young infant impedes the infant’s ability to read and respond appropriately to the mother’s cues.  This disrupts the interaction between mother and infant and inhibits attachment.  This session will explore this dynamic and present strategies for promoting attachment in infants prenatally exposed to substances of abuse.


2017 Webinar 3:

Breastfeeding Guidelines for Chemically dependent women

june 7, 11:00-12:15 p.m. Pacific Time, 1:00 - 2:15 p.m. Central Time, 2:00-3:15 p.m. Eastern time

Women with a chemical dependence frequently have poor family and social support networks and few positive relationships with other women. These factors contribute to low rates of breastfeeding in women addicted to illicit drugs. However, breastfeeding can enhance the mother/child relationship and is the healthiest means of feeding the infant. This presentation discusses the pros and cons of breastfeeding by women with a history of substance abuse and will provide guidelines that encourage breastfeeding but at the same time protect the newborn from harm by substances that cross into the breast milk.


2017 Webinar 4:

Maternal opiate use and neonatal abstinence syndrome

August 23, 11:00-12:15 p.m. Pacific Time, 1:00 - 2:15 p.m. Central Time, 2:00-3:15 p.m. Eastern time

Over the last several decades, the incidence of NAS has varied, usually associated with the waxing and waning of heroin use in the general population.  However, the current rise in the numbers of infants with NAS represents a wide spectrum of pregnant women’s use of opiates. These uses include heroin addiction, polydrug use, sanctioned and non-sanctioned prescription opioid use, and medication (methadone or buprenorphine) assisted treatment (MAT).  From the most recent data sets, it can be surmised that a significant number of cases of NAS are occurring in infants whose mothers have been prescribed opiates during the pregnancy.  In order to address the prevention of and intervention for NAS, states are in a position to develop broad systems perspectives that stretch from the preconceptional period through childhood and that address clinical and systems issues across multiple domains.


2017 Webinar 5:

Marijuana Use In Pregnancy

October 18, 11:00-12:15 p.m. Pacific Time, 1:00 - 2:15 p.m. Central Time, 2:00-3:15 p.m. Eastern time

The United States has one of the highest stillbirth rates among developed nations of the world, affecting 26,000 newborns in this country each year. Now, a new study has been published that shows that marijuana use in pregnancy increases risk of stillbirth 2.3 times.  In addition, previous studies have demonstrated the impact of prenatal exposure to marijuana on the exposed child’s long term executive functioning.  This is all against a background of numerous states passing medical marijuana laws, and critical questions of how marijuana affects pregnancy must be raised. Do any of these laws that allow the medical use of marijuana or legalize marijuana altogether consider precautions that should be taken to warn pregnant women against its use?  The answer is no.  This webinar reviews the known effects of marijuana use on pregnancy and child outcome and discusses the policy implications for new and emerging medical marijuana legislation in states across the country.


2017 Webinar 6:

Gender-specific treatment for pregnant women addicted to substances

December 6, 11:00-12:15 p.m. Pacific Time, 1:00 - 2:15 p.m. Central Time, 2:00-3:15 p.m. Eastern time

Women are different from men, but classic approaches to substance abuse treatment are based on a male-oriented model that ignores women’s lives and culture.  To address this issue, one must understand the cultural differences that play a role in defining successful substance abuse treatment for women recognize the psycho-social risk factors that commonly are found among women who abuse substances during pregnancy. This webinar will examine these issues and present gender-specific strategies that enhance the woman’s ability to achieve sobriety and a drug-free life.